IJ
Innovative Health Initiative Joint Undertaking (IHI JU)

An AI Foundation Toxicology Model and Framework to Support Waiving a Second Species in Drug Safety Studies

Funds development of an AI toxicology model that lets drug developers waive costly second-species animal safety testing.

OpenInnovative Health Initiative Joint Undertaking (IHI JU)CanadaSwitzerlandUnited KingdomSouth Korea

This IHI call funds an AI model meant to predict when testing a drug candidate in a second animal species won't add safety-relevant information, so drug developers can skip that step for small-molecule medicines without compromising patient safety. The proposal must build on named prior IMI/IHI projects -- BigPicture, eTRANSAFE, eTOX, imSAVAR and VICT3R -- plus initiatives like ASPIS and NC3Rs' Vi…

This topic funds a consortium building a validated AI Foundation Toxicology Model that predicts when a second-species chronic or sub-chronic toxicology study is unlikely to add safety-relevant information for small-molecule medicines. It also wants a standardised weight-of-evidence framework, plus tools and training material that help regulators, industry and academics adopt the model and cut reliance on animal testing.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.No fixed schedule
Next deadlineiThe next date applications are due. Rolling means you can apply any time.8 Oct 2026
Decision timeiTypical time from the deadline to the funder's decision.-
Project durationiHow long the funded work is expected to run.-
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.-
Funding pooliThe total budget available across all awards in this round.€53.2M

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides →
IJ
Open

Decode the Immunoscience of age-related diseases

🇪🇺IHI JU · European Union

Funds a research consortium that studies why immune-mediated diseases behave differently when they first strike older adults and hunts for biomarkers to predict them.

BiotechMedtech
€9.2MOct'26
IJ
Open

IHI European HealthCare Incubator Network

🇨🇦IHI JU · European Union

Funds a pan-European industry-and-academia incubator network that re-grants up to EUR 2,000,000 each to early-stage healthcare startups.

MedtechBiotech
€35MOct'26
IJ
Closed

AI-Powered Signal Detection in Pharmacovigilance

🇪🇺IHI JU · European Union

Funds one project to build AI algorithms, data-source guidance and practical tools for faster, more accurate detection of drug safety signals.

MedtechAI
€8.9M
IJ
Closed

Boosting innovation for a better understanding of the determinants of health

🇪🇺IHI JU · European Union

Funds public-private research on the determinants of health, from prevention and early diagnosis to new vaccine strategies and disease-outbreak preparedness.

Medtech
€8M – €30M
IJ
Closed

Boosting innovation for better assessment of the added value of innovative integrated healthcare solutions

🇪🇺IHI JU · European Union

Funds public-private research on new health technology assessment methods that value combined, integrated healthcare innovations fairly.

Medtech
€5M – €9.8M
IJ
Closed

Boosting innovation for people-centred integrated healthcare solutions

🇪🇺IHI JU · European Union

Funds public-private research that makes integrated healthcare solutions feasible and better matched to what patients and citizens actually need.

Medtech
€8M – €20M
European Commission logo
Scheduled

International AI Partnerships for Local Innovation

🇪🇺European Commission · European Union

Funds two €1.5M projects that adapt European AI to local data, innovation hubs and real-world challenges in low- and middle-income countries.

AgritechAI+2
€1.5MMar'27
European Commission logo
Scheduled

Cancer Mission: First-in-Human Trials for Rare Cancers

🇪🇺European Commission · European Union

Funds €7–9M projects taking biomarker-guided rare-cancer treatments into first-in-human, multicentre phase 1 trials.

BiotechMedtech+1
€7M – €9MSep'27
TIPA — Technology Innovation Promotion Agency for SMEs logo
Open

International Joint R&D Program — Phase 2 Full Collaboration

🇰🇷TIPA · South Korea

Funds Korean small businesses in full-scale joint technology development with established overseas partners.

AIHardware+6
â‚©1.39B
European Commission logo
Scheduled

Young Cancer Survivors Quality of Life Network

🇪🇺European Commission · European Union

Funds one €3M coordination action that helps cancer charities and funders improve quality of life for young survivors across Europe.

MedtechBiotech+1
€3MSep'27
European Commission logo
Scheduled

AI Predictive Biomarkers for Chronic Diseases

🇪🇺European Commission · European Union

Funds trustworthy AI biomarker methods that predict chronic-disease progression and treatment response for personalised care.

MedtechBiotech+1
€6M – €8MApr'27
European Commission logo
Scheduled

Cancer Mission: Functional Genomics for New Treatments

🇪🇺European Commission · European Union

Funds €7–8M projects that use functional genomics and patient data to uncover precise new targets for difficult-to-treat cancers.

BiotechMedtech+2
€7M – €8MSep'27